Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jeah Kyoungrae, Jung"'
Publikováno v:
BMC Health Services Research, Vol 19, Iss 1, Pp 1-17 (2019)
Abstract Background The Patient Protection and Affordable Care Act (ACA) eliminated the cost-sharing requirement for several preventive cancer screenings. This study examined the cancer screening utilization of mammogram, Pap smear and colonoscopy in
Externí odkaz:
https://doaj.org/article/83ea06a445d54bd18c3c80fd879bac40
Autor:
Jeah Kyoungrae Jung, Wendy Xu
Publikováno v:
Health Services Research. 52:1772-1793
Objective Consuming low-value health care not only highlights inefficient resource use but also brings an important concern regarding the economics of disparities. We identify the relation of socioeconomic characteristics to the use of low-value canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fa0317715e587f0294950311f9823c0
https://doi.org/10.1111/1475-6773.12559
https://doi.org/10.1111/1475-6773.12559
Publikováno v:
Medical Care Research and Review. 73:703-723
We examine consumers’ use of publicized quality information in Medicare home health care markets, where consumer cost sharing and travel costs are absent. We report two findings. First, agencies with high quality scores are more likely to be prefer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d95847e9963160a3d139370243a0556c
https://doi.org/10.1177/1077558715623718
https://doi.org/10.1177/1077558715623718
Publikováno v:
BMC Health Services Research
BMC Health Services Research, Vol 19, Iss 1, Pp 1-17 (2019)
BMC Health Services Research, Vol 19, Iss 1, Pp 1-17 (2019)
Background The Patient Protection and Affordable Care Act (ACA) eliminated the cost-sharing requirement for several preventive cancer screenings. This study examined the cancer screening utilization of mammogram, Pap smear and colonoscopy in Medicare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74f7ebcab9521511c0e17aeb0a554254
https://pubmed.ncbi.nlm.nih.gov/31208422
https://pubmed.ncbi.nlm.nih.gov/31208422
Publikováno v:
Forum for Health Economics and Policy. 20
Specialty drugs can bring substantial benefits to patients with debilitating conditions, such as cancer, but their costs are very high. Insurers/payers have increased patient cost-sharing for specialty drugs to manage specialty drug spending. We util
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::420eee099473e9afb7881f2fd9880eb2
https://doi.org/10.1515/fhep-2016-0007
https://doi.org/10.1515/fhep-2016-0007
Publikováno v:
The American journal of managed care. 22(6 Spec)
The recent arrival of new hepatitis C virus (HCV) drugs has brought fiscal pressures onto Medicare Part D; spending on HCV drugs in Part D jumped from $283 million in 2013 to $4.5 billion in 2014. We examined the current benefit designs for HCV drugs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dd5c27a4375ef29a6a01af94599b8bb4
https://pubmed.ncbi.nlm.nih.gov/27266952
https://pubmed.ncbi.nlm.nih.gov/27266952
Autor:
Hyunjee Kim, Jeah Kyoungrae Jung
Publikováno v:
Healthcare (Amsterdam, Netherlands). 3(3)
Background Medicare home health care spending increased under the prospective payment system (PPS) that was introduced specifically to control the rising spending. To explain this unexpected spending rise, we focused on new home health agencies that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::902254f3823d22b217654d811ec7740a
https://pubmed.ncbi.nlm.nih.gov/26384224
https://pubmed.ncbi.nlm.nih.gov/26384224